This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Reduction of Mammary Carcinoma

John F. O'Grady, MCh, FRCSI; Rose Marie Reichle, MEd; Margot Gruenstein; Frederick A. Reichle, MD

AMA Arch Surg. 1974;109(1):87-88.

Abstract
A reduced incidence of 9,10-dimethyl-1,2-benzanthracene (DMBA)-produced breast carcinoma has been demonstrated in rats having an end-to-side portacaval shunt. As the liver plays an important part in estrogen metabolism, the growth of established breast carcinoma in rats with and without a portacaval anastomosis was studied after bilateral ovariectomy was performed in both groups. Average increase in tumor size at death or one year after DMBA was 2.48 ±0.57 cm for rats with no shunt (sham operation) and 0.82 ± 0.39 cm for rats with a shunt (P<.05). Following bilateral ovariectomy, the suppression of DMBA-produced mammary carcinoma growth was significantly greater in the rats with a portacaval shunt.

Author Affiliations
Philadelphia

From the Department of Surgery, Agnes Barr Chase Surgical Research Laboratory, and Fels Research Institute, Temple University Health Sciences Center, Philadelphia. Dr. O'Grady is presently with the Department of Surgery, University College and St. Vincent's Hospital, Dublin.

Footnotes
Accepted for publication Jan 2, 1974.

Read in part before the American Cancer Research Association, Boston, May 6, 1972, and the Surgical Research Society, London, Jan 5, 1973.

Reprint requests to Department of Surgery, Temple University Health Sciences Center, Philadelphia, PA 19140 (Dr. Reichle).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?